| Biliary Disease |
0 |
1 |
| Metabolic Syndrome |
0 |
1 |
| Non-Alcoholic Fatty Liver Disease |
0 |
1 |
| Liver |
0 |
0.82 |
| Aminotransferase |
0 |
0.76 |
| Hepatic Fibrosis |
0 |
0.72 |
| Liver Disease |
0 |
0.72 |
| Fatty Liver |
0 |
0.63 |
| Liver Failure |
0 |
0.63 |
| Liver Biopsy |
0 |
0.59 |
| Receptors |
0 |
0.2 |
| Thyroid |
0 |
0.2 |
| Thyroid Disease |
0 |
0.2 |
| Biopsy |
0 |
0.14 |
| Clinical Research |
0 |
0.14 |
| Metabolism |
0 |
0.14 |
| Healthcare and Medical Technology |
0 |
0.13 |
| Abdominal Pain |
0 |
0.12 |
| Lipids Management |
0 |
0.12 |
| Pain Management |
0 |
0.12 |
| Cardiovascular Risk Management |
0 |
0.1 |
| LDL Cholesterol |
0 |
0.1 |
| Abdomen |
0 |
0.07 |
| Biomarker |
0 |
0.07 |
| Cirrhosis |
0 |
0.07 |
| Constipation |
0 |
0.07 |
| Diarrhea |
0 |
0.07 |
| Diet |
0 |
0.07 |
| Dizziness |
0 |
0.07 |
| Exercise |
0 |
0.07 |
| Food and Drug Administration (FDA) |
0 |
0.07 |
| Grant |
0 |
0.07 |
| Lipoproteins |
0 |
0.07 |
| Nausea |
0 |
0.07 |
| Nonalcoholic Steatohepatitis |
0 |
0.07 |
| Pain |
0 |
0.07 |
| Pruritus |
0 |
0.07 |
| Texas |
0 |
0.07 |
| Transplantation |
0 |
0.07 |